Display options
Share it on

Evid Based Complement Alternat Med. 2012;2012:508623. doi: 10.1155/2012/508623. Epub 2012 Dec 06.

Depression, Comorbidities, and Prescriptions of Antidepressants in a German Network of GPs and Specialists with Subspecialisation in Anthroposophic Medicine: A Longitudinal Observational Study.

Evidence-based complementary and alternative medicine : eCAM

Elke Jeschke, Thomas Ostermann, Horst C Vollmar, Manuela Tabali, Harald Matthes

Affiliations

  1. Havelhoehe Research Institute, Kladower Damm 221, 14089 Berlin, Germany.

PMID: 23304204 PMCID: PMC3529476 DOI: 10.1155/2012/508623

Abstract

Background. Depression is a major reason for counselling in primary care. Our study aims at evaluating pharmacological treatment strategies among physicians specialised in anthroposophic medicine (AM). Methods. From 2004 to 2008, twenty-two German primary care AM-physicians participated in this prospective, multicentre observational study. Multiple logistic regression was used to determine factors associated with a prescription of any antidepressant medication. Results. A total of 2444 patients with depression were included (mean age: 49.1 years (SD: 15.4); 77.3% female). 2645 prescriptions of antidepressants for 833 patients were reported. Phytotherapeutic preparations from Hypericum perforatum were the most frequently prescribed antidepressants over all (44.6% of all antidepressants), followed by amitriptyline (16.1%). The likelihood of receiving an antidepressant medication did not depend on comorbidity after controlling for age, gender, physician specialisation, and type of depression (adjusted OR (AOR) = 1.01; CI: 0.81-1.26). Patients who had cancer were significantly less likely to be prescribed an antidepressant medication than those who had no cancer (AOR = 0.75; CI: 0.57-0.97). Conclusion. This study provides a comprehensive analysis of everyday practice for the treatment of depression in AM -physicians. Further analysis regarding the occurrence of critical combinations is of high interest to health services research.

References

  1. J Am Board Fam Pract. 2005 Mar-Apr;18(2):79-86 - PubMed
  2. Gesundheitswesen. 2008 Jan;70(1):54-60 - PubMed
  3. Psychol Med. 2004 May;34(4):597-611 - PubMed
  4. J Clin Psychiatry. 2011 Jun;72(6):795-805 - PubMed
  5. J Fam Pract. 2000 Jan;49(1):68-72 - PubMed
  6. PLoS Med. 2006 Jul;3(7):e240 - PubMed
  7. Int J Qual Health Care. 2006 Apr;18(2):113-9 - PubMed
  8. Int Clin Psychopharmacol. 2001 May;16(3):121-35 - PubMed
  9. J Clin Psychiatry. 1990 Jun;51 Suppl:3-11; discussion 12-4 - PubMed
  10. J Affect Disord. 2009 Oct;117 Suppl 1:S54-64 - PubMed
  11. Eur Neuropsychopharmacol. 2010 Nov;20(11):747-65 - PubMed
  12. PLoS Med. 2008 Feb;5(2):e45 - PubMed
  13. Eur J Epidemiol. 2007;22(6):397-403 - PubMed
  14. JAMA. 1999 Nov 10;282(18):1737-44 - PubMed
  15. Int J Psychiatry Med. 2008;38(2):203-15 - PubMed
  16. Nervenarzt. 2010 Sep;81(9):1049-68 - PubMed
  17. Cochrane Database Syst Rev. 2008 Oct 08;(4):CD000448 - PubMed
  18. Altern Med Rev. 2011 Mar;16(1):40-9 - PubMed
  19. Lancet. 2007 Sep 8;370(9590):851-8 - PubMed
  20. J Manag Care Pharm. 2012 Jul-Aug;18(6):427-38 - PubMed
  21. Forsch Komplementmed. 2009 Oct;16(5):325-33 - PubMed
  22. J Am Board Fam Med. 2010 Jul-Aug;23(4):499-508 - PubMed
  23. Soc Psychiatry Psychiatr Epidemiol. 2010 Mar;45(3):329-35 - PubMed

Publication Types